Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw strong trading volume on Thursday . 52,380 shares traded hands during trading, an increase of 165% from the previous session’s volume of 19,752 shares.The stock last traded at $3.3080 and had previously closed at $3.43.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.
Read Our Latest Research Report on RADLY
Raia Drogasil Stock Down 1.4%
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Read More
- Five stocks we like better than Raia Drogasil
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
